Summary of safety results
| n/N (%) | RA | AS | PsA | PS |
|---|---|---|---|---|
| TEAE | 198/400 (49.5) | 183/531 (34.5) | 1/3 (33.3) | 3/6 (50.0) |
| TEAE related with CT-P13 | 73/400 (18.3) | 64/531 (12.1) | 0/3 (0.0) | 2/6 (33.3) |
| TESAE | 52/400 (13.0) | 14/531 (2.6) | 0/3 (0.0) | 1/6 (16.7) |
| TESAE related with CT-P13 | 15/400 (3.8) | 6/531 (1.1) | 0/3 (0.0) | 0/6 (0.0) |
| Infusion-related reactions | 28/400 (7.0) | 11/531 (2.1) | 0/3 (0.0) | 0/6 (0.0) |